Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (
ClinicalTrials.gov study NCT06345729. IPD Sharing: YES. Countries: 27. Publications: 0.
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
ClinicalTrials.gov study NCT03597581. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04479306. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
ClinicalTrials.gov study NCT06047379. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status.
ClinicalTrials.gov study NCT05785208. IPD Sharing: NO. Countries: 1. Publications: 0.
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06336902. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
ClinicalTrials.gov study NCT05303519. IPD Sharing: NO. Countries: 3. Publications: 0.
Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type
ClinicalTrials.gov study NCT03714958. IPD Sharing: NO. Countries: 1. Publications: 0.
Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following F
ClinicalTrials.gov study NCT07397819. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer
ClinicalTrials.gov study NCT05622058. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Study of HL-085 Plus Docetaxel in Patients With KRAS Mutant NSCLC
ClinicalTrials.gov study NCT03990077. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
e- Ab Sensor-based Real-time Detection of Mutant EGFR in Clinical Specimens From Patients of Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01359436. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01402440. IPD Sharing: Not stated. Countries: 10. Publications: 0.
A Phase II Study of Atezolizumab in Combination With Bevacizumab, Carboplatin or Cisplatin, and Pemetrexed for EGFR-mutant Metastatic Non-small Cell Lung Cancer Patients After Failure of EGFR Tyrosine
ClinicalTrials.gov study NCT04147351. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma
ClinicalTrials.gov study NCT03754179. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
ClinicalTrials.gov study NCT05843253. IPD Sharing: NO. Countries: 7. Publications: 0.
Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST
ClinicalTrials.gov study NCT05970900. IPD Sharing: NO. Countries: 1. Publications: 0.
AMG510 (sotorasib) Plus Lenvatinib As Second-line Treatment in Patients with KRASG12C Mutant, Metastatic NSCLC
ClinicalTrials.gov study NCT06068153. IPD Sharing: YES. Countries: 4. Publications: 0.
A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
ClinicalTrials.gov study NCT02321293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer
ClinicalTrials.gov study NCT06970353. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.